Platinum Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
BCM
SCM
EC
Platinum Investment Management's IRWD Position: Q4 2018 in Review
Platinum Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2018, closing a stake of 81,908 shares — an estimated $1.27M sold.
Platinum Investment Management first reported a position in IRWD in Q2 2013 and held it in 22 quarters. The position peaked at $2.44M in Q3 2016. 145 funds tracked by Wall St. Rank hold IRWD as of Q4 2018.
- Platinum Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
- Platinum Investment Management sold 81,908 Ironwood Pharmaceuticals shares in Q4 2018, an estimated $1.27M.
- Platinum Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 22 quarters.
- Platinum Investment Management's Ironwood Pharmaceuticals position peaked at $2.44M in Q3 2016.
- 145 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2018.
Based on Platinum Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.